Import Alert On Drugs From Ranbaxy’s Plants Includes OTC Product

India's largest drug maker, Ranbaxy, faces a hurdle to growing its U.S. business with FDA's ban on imports of some of its products, including an OTC drug

More from Archive

More from Pink Sheet